#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immune-mediated myositis Hereditary haemorrhagic telangiectasia Ureteric cancer Phaeochromocytoma Neuroendocrine carcinoma metastatic Peritoneal mesothelioma malignant Indolent systemic mastocytosis Malignant peritoneal neoplasm Arterial disorder Microvillous inclusion disease Aspergillus infection Laryngeal squamous cell carcinoma Aicardi-Goutieres syndrome Kawasaki's disease Langerhans' cell histiocytosis More trials…

    Learn about Rare Diseases

    Carcinoid syndrome Synovial sarcoma metastatic – Diagnostics Chondrosarcoma metastatic – Diagnostics Usher’s syndrome – Diagnostics Medulloblastoma – Basic Information Pulmonary sarcoidosis – Treatment Leukoencephalopathy – Life with Disease Systemic mastocytosis – Basic Information Skin angiosarcoma – Diagnostics Leiomyosarcoma metastatic – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    PRILOCAINE HYDROCHLORIDE Alisertib Sodium Ucp2 Sar444656 Vanglusagene Ensiparvovec Clemastine Fumarate Gs-5718-03 Siltuximab Darbepoetin Alfa Sacubitril Valsartan Vx-522 Pioglitazone Hydrochloride Mebeverine Hydrochloride Levobupivacaine Hydrochloride Iph5201 Carmustine TTX-381 VANADIUM OXIDE SULFATE Cd7-Cart01 Gallium Citrate Ga-68 More therapies…

    Learn about Your Condition

    Primary biliary cholangitis Polycythaemia vera Factor VIII deficiency Muscle injury Lichen planopilaris Metastases to meninges Neurofibromatosis Head and neck cancer Subdural haematoma Carotid artery occlusion Medulloblastoma Post cardiac arrest syndrome Leukocyte adhesion deficiency Spinal pain Langerhans cell sarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Long-Term Study of Ustekinumab for Patients with Crohn’s Disease Who Previously Lost Response to Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Ustekinumab
    Belgium

  • Long-term safety study of apraglutide (weekly injections) in patients with Short Bowel Syndrome

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Short-bowel syndrome
    Investigated Drugs:
    • Apraglutide
    Belgium Czechia Denmark France Germany Hungary +5

  • Study on the Effectiveness and Safety of Guselkumab for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    4 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Guselkumab
    Belgium Bulgaria Czechia France Germany Hungary +7

  • Study on Ramucirumab and Paclitaxel for Older Patients with Advanced Stomach Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastric cancer
    Investigated Drugs:
    • Ramucirumab
    • Paclitaxel
    France

  • Study on Treatment for Colorectal Liver Metastases Using Heparin, Dexamethasone, and Floxuridine for Patients with Heavy Tumor Burden

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Metastases to liver
    Investigated Drugs:
    • Dexamethasone Acetate
    • Dexamethasone Sodium Phosphate
    • Floxuridine
    Norway

  • Study on the Effectiveness and Safety of Barzolvolimab in Adults with Active Eosinophilic Esophagitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Eosinophilic oesophagitis
    Investigated Drugs:
    • Barzolvolimab
    • Epinephrine
    Germany Italy Poland Spain
Previous Page
1 … 79 80 81 82 83 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!